Evidence map›Paper›PMID 40695895›Full record

ArticleScientific reports2025

A cross-sectional analysis of remnant cholesterol-diabetes association in US adults.

Xiangying Li, Gang Cui, Xuemin Wang

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Xiangying LiDepartment of Emergency Medicine and Intensive Care, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 746 Zhongshan Middle Road, Shanghai, 201600, China.
Gang CuiDepartment of Neurosurgery & Brain and Nerve Research Laboratory, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, 215006, China. gangcui818@163.com.
Xuemin WangDepartment of Emergency Medicine and Intensive Care, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 746 Zhongshan Middle Road, Shanghai, 201600, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between remnant cholesterol and diabetes is a critical issue in the fields of health and public health. Currently, the relationship between remnant cholesterol (RC) and diabetes is a highly researched and trending topic. The aim of this study was to investigate association between RC and diabetes in US individuals. The secondary objective of this study was to explore the potential dose-response relationship between the exposure RC and diabetes. Our study utilized all available continuous data from the National Health and Nutrition Examination Survey (NHANES) from 2013 to 2018. Multivariable logistic regression models were used to investigate the association between RC and diabetes. The association between RC and diabetes was assessed using smoothing splines generated by generalized additive models. Additionally, a threshold effect analysis of the relationship between RC and diabetes was conducted. Analysis of 6,875 eligible adults (derived from an initial cohort of 7,780 after exclusions for missing diabetes/cholesterol data) revealed a significant threshold effect at 19 mg/dLof remnant cholesterol (RC) for diabetes prevalence. Participants with RC < 19 mg/dL exhibited substantially elevated diabetes odds in both unadjusted (OR = 1.80, 95% CI: 1.57-2.06; P < 0.001) and fully adjusted models (OR = 1.46, 95% CI: 1.30-1.64; P < 0.001), whereas RC ≥ 19 mg/dL demonstrated no significant association (adjusted OR = 0.99, 95% CI: 0.88-1.25; P = 0.96). Quartile analysis confirmed a robust dose-dependent relationship: compared to Quartile 1 (RC ≤ 12 mg/dL; reference), diabetes odds progressively increased to OR = 1.72 (95% CI: 1.37-2.16)​for Quartile 2 (13-18 mg/dL), OR = 2.32 (95% CI: 1.86-2.91) for Quartile 3 (19-26 mg/dL), and OR = 3.42 (95% CI: 2.77-4.21)​for Quartile 4 (27-80 mg/dL), with significant trend persistence after multivariable adjustment (P < 0.001). These associations remained significant despite substantial demographic variations across RC quartiles, including differences in age (P < 0.001), sex distribution (P < 0.001), and racial/ethnic composition (P < 0.001). This cross-sectional analysis observed that elevated RC levels were significantly associated with higher prevalence of diabetes in adults aged 20-80 years, with a threshold value of 19 mg/dL for increased association strength. The findings support RC as a metabolic marker associated with prevalent diabetes with a threshold value of 19 mg/dL for strengthened association.

Indexed as

CholesterolDiabetes MellitusTriglyceridesAdultAgedCross-Sectional StudiesFemaleHumansLipoproteinsMaleMiddle AgedNutrition SurveysPrevalenceRisk FactorsUnited StatesCholesterolLipoproteinsremnant-like particle cholesterolTriglyceridesCross-sectional studyDiabetesNational health and nutrition examination surveyRemnant cholesterol (RC)

Identifiers

PMID40695895
PMCPMC12283965

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.